Anderson Wesley L, Torabi Asad J, O'leary Brian A, Breall Jeffrey A, Sinha Anjan K, Jaradat Ziad A, Morris Michelle C, Frick Kyle A, Romeh Ibrahim A, Iqtidar Ali F, von der Lohe Elisabeth, Kreutz Rolf P
Department of Medicine, Division of Cardiovascular Medicine Indiana University School of Medicine Indianapolis Indiana USA.
Health Sci Rep. 2024 Dec 19;7(12):e70256. doi: 10.1002/hsr2.70256. eCollection 2024 Dec.
Femoral artery access is widely used despite recent increase in radial access for percutaneous coronary interventions (PCI). Femoral artery closure devices are used to shorten vascular closure time and reduce bleeding. We sought to examine sex-based outcomes of femoral artery vascular closure devices (VCD) in patients undergoing PCI.
We identified patients who had undergone PCI ( = 11,415) in the Indiana University Health Multicenter Cardiac Cath registry using femoral artery access. Clinical outcomes were compared between VCD and manual compression and analyzed according to sex. Patients with cardiogenic shock and left ventricular support devices were excluded.
The use of any vascular closure device as compared to femoral artery manual compression was associated with a reduction in 72-h bleeding events (adjusted odds ratio [OR]: 0.64; 95% confidence interval [CI]: 0.46-0.87). With manual compression, women had higher rates of 72-h bleeding as compared to men (4.5% vs. 1.6%, < 0.001). Women demonstrated greater absolute risk reduction in 72-h bleeding events with use of VCD as compared to men (2.8% vs. 0.8%, < 0.001). For women, VCD were associated with lower risk of access site bleeding (OR: 0.43; 95% CI: 0.24-0.8), hematoma (OR: 0.36; 95% CI: 0.2-0.63), and vascular complications (OR: 0.25, 95% CI: 0.09-0.72). Use of VCD was associated with lower risk of in-hospital death (adjusted OR: 0.4; 95% CI: 0.28-0.58; < 0.001) in multivariable regression analysis.
Women derive more benefit from use of femoral artery VCD during PCI than men with greater reduction in bleeding rates, access site hematoma, and vascular complications.
尽管近年来经皮冠状动脉介入治疗(PCI)采用桡动脉入路的情况有所增加,但股动脉入路仍被广泛使用。股动脉闭合装置用于缩短血管闭合时间并减少出血。我们试图研究接受PCI的患者使用股动脉血管闭合装置(VCD)的性别差异结果。
我们在印第安纳大学健康多中心心脏导管注册研究中,确定了11415例采用股动脉入路接受PCI的患者。比较了VCD组和手动压迫组的临床结果,并按性别进行分析。排除心源性休克和左心室支持装置的患者。
与股动脉手动压迫相比,使用任何血管闭合装置均与72小时出血事件减少相关(调整后的优势比[OR]:0.64;95%置信区间[CI]:0.46 - 0.87)。采用手动压迫时,女性72小时出血率高于男性(4.5%对1.6%,P < 0.001)。与男性相比,女性使用VCD后72小时出血事件的绝对风险降低幅度更大(2.8%对0.8%,P < 0.001)。对于女性,VCD与较低的穿刺部位出血风险(OR:0.43;95% CI:0.24 - 0.8)、血肿风险(OR:0.36;95% CI:0.2 - 0.63)和血管并发症风险(OR:0.25,95% CI:0.09 - 0.72)相关。在多变量回归分析中,使用VCD与较低的住院死亡风险相关(调整后的OR:0.4;95% CI:0.28 - 0.58;P < 0.001)。
在PCI期间,女性使用股动脉VCD比男性获益更多,出血率、穿刺部位血肿和血管并发症的降低幅度更大。